Liechtenstein - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes
Since 2014, Liechtenstein Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes was up 0.9% year on year. With €527.16 Per Capita in 2019, the country was number 3 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes. Liechtenstein is overtaken by Germany, which was number 2 at €553.39 Per Capita and is followed by Ireland at €447.21 Per Capita. Switzerland lead the ranking with €666.37 Per Capita in 2019, a growth of 3.2% versus 2018. Latvia witnessed the best average annual growth at +8.8% per year, while Romania witnessed the worst performance at -1.7% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 527.16 |
| 2018 | 509.91 |
| 2017 | 543.52 |
| 2016 | 597.98 |
| 2015 | 595.12 |
How does Liechtenstein rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
666.37 | 2019 | +3.1 % | +5.3 % | View data |
| 2 |
#2
Germany
|
553.39 | 2019 | +2.3 % | +3.0 % | View data |
| 3 |
#3
Liechtenstein
|
527.16 | 2019 | +3.4 % | +0.9 % | View data |
| 4 |
#4
Ireland
|
447.21 | 2019 | -0.8 % | +2.1 % | View data |
| 5 |
#5
Belgium
|
429.86 | 2019 | +0.5 % | +4.4 % | View data |